Detalles de la búsqueda
1.
Efficacy and Safety of Bezafibrate Alone or in Combination with Ursodeoxycholic Acid in Primary Biliary Cholangitis: Systematic Review and Meta-Analysis.
Dig Dis Sci
; 68(4): 1559-1573, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36180756
2.
Differential effects on renal function and glucose metabolism of renal dependent bezafibrate and non-renal dependent pemafibrate in patients with hypertriglyceridemia.
Int J Clin Pharmacol Ther
; 61(10): 437-444, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37548458
3.
Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial.
Gastroenterology
; 160(3): 734-743.e6, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33031833
4.
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis.
N Engl J Med
; 378(23): 2171-2181, 2018 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29874528
5.
Safety of fibrates in cholestatic liver diseases.
Liver Int
; 41(6): 1335-1343, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33751787
6.
Lipid-lowering agent-triggered dermatomyositis and polymyositis: a case series and literature review.
Rheumatol Int
; 38(2): 293-301, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29027009
7.
[Modern treatment of primary biliary cholangitis]. / Moderne Therapie der primär biliären Cholangitis.
Internist (Berl)
; 59(1): 105-112, 2018 01.
Artículo
en Alemán
| MEDLINE | ID: mdl-29110023
8.
Effect of adding bezafibrate to standard lipid-lowering therapy on post-fat load lipid levels in patients with familial dysbetalipoproteinemia. A randomized placebo-controlled crossover trial.
J Lipid Res
; 58(11): 2180-2187, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28928170
9.
Improved Markers of Cholestatic Liver Injury in Patients With Primary Biliary Cholangitis Treated With Obeticholic Acid and Bezafibrate.
Hepatology
; 73(6): 2598-2600, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33140868
10.
Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial.
Cardiovasc Diabetol
; 15: 11, 2016 Jan 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-26794137
11.
A prospective randomized controlled study of long-term combination therapy using ursodeoxycholic acid and bezafibrate in patients with primary biliary cirrhosis and dyslipidemia.
Am J Gastroenterol
; 110(3): 423-31, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25732417
12.
Extreme urinary betaine losses in type 2 diabetes combined with bezafibrate treatment are associated with losses of dimethylglycine and choline but not with increased losses of other osmolytes.
Cardiovasc Drugs Ther
; 28(5): 459-68, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25060556
13.
Safety and efficacy of long-term combination therapy with bezafibrate and ezetimibe in patients with dyslipidemia in the prospective, observational J-COMPATIBLE study.
Cardiovasc Diabetol
; 12: 163, 2013 Nov 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-24195788
14.
Mitochondrial dysfunction, oxidative stress, ER stress and mitochondria-ER crosstalk alterations in a chemical rat model of Huntington's disease: Potential benefits of bezafibrate.
Toxicol Lett
; 381: 48-59, 2023 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37116597
15.
Effects of bezafibrate on lipid and glucose metabolism in dyslipidemic patients with diabetes: the J-BENEFIT study.
Cardiovasc Diabetol
; 11: 29, 2012 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-22439599
16.
Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?
Cardiovasc Diabetol
; 11: 140, 2012 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-23150952
17.
Bezafibrate for primary biliary cirrhosis.
Cochrane Database Syst Rev
; 1: CD009145, 2012 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-22259000
18.
Combination treatment with statins and bezafibrate induces myotoxicity via inhibition of geranylgeranyl pyrophosphate biosynthesis and Rho activation in L6 myoblasts and myotube cells.
J Physiol Pharmacol
; 73(1)2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35793766
19.
The effect of bezafibrate and omega-3 fatty acids on lymphocyte cytokine release and systemic inflammation in patients with isolated hypertriglyceridemia.
Eur J Clin Pharmacol
; 67(11): 1109-17, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21630032
20.
Combined bezafibrate and medroxyprogesterone acetate have efficacy without haematological toxicity in elderly and relapsed acute myeloid leukaemia (AML).
Br J Haematol
; 149(1): 65-9, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20067564